| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $182.4M | +44.6% |
| SG&A Expense | $52.0M | -14.4% |
| Operating Income | -$234.4M | -25.4% |
| Interest Expense | $0 | — |
| Pre-tax Income | -$229.9M | -30.5% |
| Income Tax | $52K | +160.0% |
| Net Income | -$230.0M | -30.5% |
| EPS (Basic) | -$4.32 | -29.0% |
| EPS (Diluted) | -$4.32 | -29.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $209.9M | +24.9% |
| Current Assets | $214.8M | +24.9% |
| Total Assets | $351.5M | +4.8% |
| Current Liabilities | $45.5M | +78.1% |
| Total Liabilities | $194.2M | +4.8% |
| Stockholders' Equity | $157.4M | +4.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$136.0M | -15.9% |
| Capital Expenditures | $506K | +34.9% |
| Investing Cash Flow | -$506K | +33.0% |
| Financing Cash Flow | $178.3M | — |
| Free Cash Flow | -$136.5M | -16.0% |